Skip to main content

Table 4 Quality appraisal of identified studies$

From: A rapid state-of the-art review of client-reported outcomes measures used to assess dogs’ clinical signs and quality of life during chemotherapy

Study reference (country)

1.Purpose/intended population

2.Actual content (face validity)

3.Item identification

4.Item selection

5.Uni-dimensionality

6.Response scale

7.Convergent validity

8.Discriminant validity

9.Predictive validity

10.Test-rest reliability

11.Responsiveness

Total QAF score

Mellanby et al., 2003 (UK)

X

X

X

X

X

X

X

X

X

3

Bowles et al., 2010 (New Zealand)

X

X

X

X

X

X

X

X

X

2

Rau et al., 2010 (USA)

X

X

X

X

X

X

X

X

5

Lynch et al., 2011, UK*

X

X

X

X

X

X

X

6

Hamilton et al., 2012 (USA)*

X

X

X

X

X

X

X

X

X

3

Iliopoulou et al., 2013 (USA)*

X

X

X

X

X

X

6

Bianchi et al., 2021 (Italy)

X

X

X

X

X

X

X

X

5

Fournier et al., 2021 (UK)

X

X

X

X

X

X

X

6

Jugan et al., 2021 (USA)

X

X

X

X

X

X

7

Matsuyama et al., 2021 (Japan)

X

X

X

X

X

X

X

X

3

Total for specific QAF criteria

17

14

1

0

1

9

0

0

3

0

1

-

  1. $ For definitions of assessment criteria see Table 2. *Denotes primary focus was CROM development/validation